Haemostatic system activation and prediction of vascular events in patients presenting with stable peripheral arterial disease of moderate severity

被引:14
作者
Boneu, B
Leger, P
Arnaud, C
机构
[1] Hop Purpan, Lab Rech Hemostase & Thrombose, F-31059 Toulouse, France
[2] Econ Sante & Sante Commun, Dept Epidemiol, Toulouse, France
[3] Econ Sante & Sante Commun, Serv Med Interneangiol, Toulouse, France
[4] Econ Sante & Sante Commun, Lab Rech Hemostase & Thrombose, Toulouse, France
关键词
D-dimers; thrombin-antithrombin complexes; plasminogen activator inhibitor; hypercoagulability; epidemiology; peripheral arterial disease; ischaemia;
D O I
10.1097/00001721-199803000-00003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study reports on the predictive value of some haemostatic factors [fibrinogen, factor VII and plasminogen activator inhibitor (PAI)], a marker of endothelial damage (soluble thrombomodulin) and several markers of haemostatic system activation (factor VIIa, prothrombin fragment 1+2, thrombin-antithrombin complexes and D-dimers) on the incidence of vascular events in male, non-diabetic patients with chronic ischaemia of the lower limbs. The patients (n = 324) were recruited consecutively in the thermal resort of Royat, France. The low incidence of death from vascular causes during the 2-year survey period (two patients) and the high percentage of former smokers (71%) indicated that this population of patients was affected by an arteriopathy of moderate intensity. After 2 years' follow-up, vascular events had occurred in 51 patients. The clinical and biological profiles did not differ significantly between patients with and without vascular events. However, the risk of vascular events during the 2 years of followup was significantly higher in those with high levels of PAI antigen and thrombin-antithrombin complexes. Thus, even in a population of patients with only moderately severe arteriopathy, high levels of thrombin-antithrombin complexes and PAI are predictive of vascular complications. (C) 1998 Lippincott-Raven Publishers.
引用
收藏
页码:129 / 135
页数:7
相关论文
共 22 条
[1]  
ALZAHRANI H, 1992, CLIN HEMORHEOL, V12, P867
[2]  
BANERJEE AK, 1992, THROMB HAEMOSTASIS, V68, P261
[3]  
CLEEMAN JI, 1988, ARCH INTERN MED, V148, P36, DOI 10.1001/archinte.148.1.36
[4]   THE PLAT STUDY - HEMOSTATIC FUNCTION IN RELATION TO ATHEROTHROMBOTIC ISCHEMIC EVENTS IN VASCULAR-DISEASE PATIENTS PRINCIPAL RESULTS [J].
CORTELLARO, M ;
BOSCHETTI, C ;
COFRANCESCO, E ;
ZANUSSI, C ;
CATALANO, M ;
DEGAETANO, G ;
GABRIELLI, L ;
LOMBARDI, B ;
SPECCHIA, G ;
TAVAZZI, L ;
TREMOLI, E ;
DELLAVOLPE, A ;
POLLI, E ;
AGRIFOGLIO, G ;
BUGIANI, O ;
COBELLI, F ;
DONATI, MB ;
GARATTINI, S ;
LIBRETTI, A ;
MANTEGAZZA, P ;
MONTEMARTINI, C ;
PAOLETTI, R .
ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (09) :1063-1070
[5]   FIBRINOGEN AS A CARDIOVASCULAR RISK FACTOR - A METAANALYSIS AND REVIEW OF THE LITERATURE [J].
ERNST, E ;
RESCH, KL .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (12) :956-963
[6]   ASSOCIATION OF HEMOSTATIC VARIABLES WITH PREVALENT CARDIOVASCULAR-DISEASE AND ASYMPTOMATIC CAROTID-ARTERY ATHEROSCLEROSIS [J].
FOLSOM, AR ;
WU, KK ;
SHAHAR, E ;
DAVIS, CE .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (12) :1829-1836
[7]   CROSS-LINKED FIBRIN DEGRADATION PRODUCTS, PROGRESSION OF PERIPHERAL ARTERIAL-DISEASE, AND RISK OF CORONARY HEART-DISEASE [J].
FOWKES, FGR ;
LOWE, GDO ;
HOUSLEY, E ;
RATTRAY, A ;
RUMLEY, A ;
ELTON, RA ;
MACGREGOR, IR ;
DAWES, J .
LANCET, 1993, 342 (8863) :84-86
[8]   PREDICTION OF CAROTID STENOSIS PROGRESSION BY LIPID AND HEMATOLOGIC MEASUREMENTS [J].
GROTTA, JC ;
YATSU, FM ;
PETTIGREW, LC ;
RHOADES, H ;
BRATINA, P ;
VITAL, D ;
ALAM, R ;
EARLS, R ;
PICONE, C .
NEUROLOGY, 1989, 39 (10) :1325-1331
[9]  
HAMSTEN A, 1987, LANCET, V2, P3
[10]   INCREASED PLASMA-LEVELS OF A RAPID INHIBITOR OF TISSUE PLASMINOGEN-ACTIVATOR IN YOUNG SURVIVORS OF MYOCARDIAL-INFARCTION [J].
HAMSTEN, A ;
WIMAN, B ;
DEFAIRE, U ;
BLOMBACK, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (25) :1557-1563